F2A-10712-23198
5 vaccinations
8 coded responses
68 check-ins
7 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 522 / IA
- Registered
- 2021-01-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-11
Registered in v-safe
-
2021-01-11
Dose 1 — Pfizer-BioNTech
- 2021-01-11
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-25
- 2021-02-01
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-02-03
Survey response — day 0, dose 2MedDRA: Dysgeusia — Feeling: Good · Site: PainFree text: Soon after injection had a metallic taste in my mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Breath odour, Dysgeusia, Taste disorder — Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Abnormal taste like horrible bad breath with a metallic taste unaffected by brushing teethMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
- 2021-05-05
- 2021-08-04
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-10-08
Survey response — days 1–6 daily, dose 3MedDRA: Epistaxis — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Had a nose bleed. Never had a nose bleed before may have nothing to do with vaccine reporting since first occurrenceMedDRA releases: 2024-11 · check-in free text available
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
-
2021-11-08
Survey response — day 35, dose 3MedDRA: Hepatic enzyme increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Elevated liver enzymesMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-10
- 2021-11-15
- 2021-11-18
- 2022-01-03
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Blood calcium increased, Blood parathyroid hormone increased — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Elevated parathyroid hormone, elevated calicumMedDRA releases: 2024-11 · check-in free text available
-
2022-04-04
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-04-05
Call successfulNot applicable - Accidental Reporting
-
2022-04-05
Call successfulNot applicable - Accidental Reporting
-
2022-04-08
Dose 4 — Pfizer-BioNTech
-
2022-04-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-04-11
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-04-12
- 2022-04-13
- 2022-04-14
- 2022-04-15
- 2022-04-22
- 2022-04-29
- 2022-05-06
- 2022-05-13
- 2022-05-20
-
2022-07-08
Survey response — 3 months, dose 4MedDRA: Adenoma benign, Hyperparathyroidism primary, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Primary Hyperparathyrodism/adenoma · Healthcare visit (other): Nuclear scan, ultrasound, scheduled endocrine surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-07-08
Report sent to call center — 3 months, dose 4Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-07-12
Call successfulNot applicable - Accidental Reporting
-
2022-10-21
Dose 5 — Moderna
- 2022-10-21
-
2022-10-22
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-24
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-10-25
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
-
2022-12-02
Survey response — day 42, dose 5MedDRA: Knee arthroplasty — Feeling: Fair · Be unable to work or attend schoolFree text: Knee replacementMedDRA releases: 2024-11 · check-in free text available
- 2023-01-20
-
2023-04-21
Survey response — 6 months, dose 5MedDRA: Hyperparathyroidism, Hyperthyroidism, Knee arthroplasty, Non-alcoholic fatty liver, Parathyroidectomy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationMedDRA releases: 2024-11
-
2023-04-21
Report sent to call center — 6 months, dose 5Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
-
2023-04-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-11 | Pfizer-BioNTech | |
| 2 | 2021-02-03 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-04-08 | Pfizer-BioNTech | No |
| 5 | 2022-10-21 | Moderna | No |
Call center
5 call center cases
4 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — day 0, dose 2
Systemic reaction (other): Soon after injection had a metallic taste in my mouth
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Abnormal taste like horrible bad breath with a metallic taste unaffected by brushing teeth
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Had a nose bleed. Never had a nose bleed before may have nothing to do with vaccine reporting since first occurrence
Release 10 — day 35, dose 3
Symptoms: Elevated liver enzymes
Release 11 — 6 months, dose 3
Symptoms: Elevated parathyroid hormone, elevated calicum
Release 12 — 3 months, dose 4
Symptoms: Primary Hyperparathyrodism/adenoma
Healthcare visit (other): Nuclear scan, ultrasound, scheduled endocrine surgery
Release 12 — day 42, dose 5
Symptoms: Knee replacement
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Knee arthroplasty | · | · | ✓ |
| HCVO | Parathyroidectomy | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Adenoma benign | · | · | ✓ |
| SD | Blood calcium increased | · | · | ✓ |
| SD | Blood parathyroid hormone increased | · | · | ✓ |
| SD | Hepatic enzyme increased | · | · | ✓ |
| SD | Hyperparathyroidism | · | · | ✓ |
| SD | Hyperparathyroidism primary | · | · | ✓ |
| SD | Hyperthyroidism | · | · | ✓ |
| SD | Knee arthroplasty | · | · | ✓ |
| SD | Non-alcoholic fatty liver | · | · | ✓ |
| SRO | Breath odour | ✓ | ✓ | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Epistaxis | · | · | ✓ |
| SRO | Taste disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release